Abstract

High expression levels of the calcium-binding proteins S100A8 and S100A9 in myeloid cells in kidney transplant rejections are associated with a favorable outcome. Here we investigated the myeloid cell subset expressing these molecules, and their function in inflammatory reactions. Different monocyte subsets were sorted from buffy coats of healthy donors and investigated for S100A8 and S100A9 expression. To characterize S100A9high and S100A9low subsets within the CD14+ classical monocyte subset, intracellular S100A9 staining was combined with flow cytometry (FACS) and qPCR profiling. Furthermore, S100A8 and S100A9 were overexpressed by transfection in primary monocyte-derived macrophages and the THP-1 macrophage cell line to investigate the functional relevance. Expression of S100A8 and S100A9 was primarily found in classical monocytes and to a much lower extent in intermediate and non-classical monocytes. All S100A9+ cells expressed human leukocyte antigen—antigen D related (HLA-DR) on their surface. A small population (<3%) of CD14+ CD11b+ CD33+ HLA-DR− cells, characterized as myeloid derived suppressor cells (MDSCs), also expressed S100A9 to high extent. Overexpression of S100A8 and S00A9 in macrophages led to enhanced extracellular reactive oxygen species (ROS) production, as well as elevated mRNA expression of anti-inflammatory IL-10. The results suggest that the calcium-binding proteins S100A8 and S100A9 in myeloid cells have an immune regulatory effect.

Highlights

  • The S100 calcium-binding proteins A8 and A9 (S100A8 and S100A9), known as migration inhibitory factor-related proteins 8 (MRP8) and 14 (MRP14), are abundantly expressed in myeloid cells, such as circulating monocytes and neutrophils

  • Protein expression of S100A9 by flow cytometry was seen in all three monocyte subsets, and it was higher than that seen in lymphocytes (Figure 1C,D)

  • The results show that S100A9 is mostly expressed in CD14-positive monocytes

Read more

Summary

Introduction

The S100 calcium-binding proteins A8 and A9 (S100A8 and S100A9), known as migration inhibitory factor-related proteins 8 (MRP8) and 14 (MRP14), are abundantly expressed in myeloid cells, such as circulating monocytes and neutrophils. Their level of expression can be used as a biomarker of inflammation in bacterial infections and autoimmune diseases [1,2,3,4,5]. Sinha and colleagues reported that S100A8/A9 binds to glycoprotein receptors on MDSCs and promotes their migration and accumulation [15]. S100A9 was proposed as a novel marker of human monocytic MDSCs [16]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call